Abstract
Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82%) required palliative treatment, and eight (18%) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4% of patients and in hospital for 40.5%. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6% and 65%, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.
| Original language | English |
|---|---|
| Journal | European Journal of Haematology |
| DOIs | |
| Publication status | Published - Jan 1 2019 |
Fingerprint
Keywords
- acute leukaemia
- home care
- palliative care
- supportive care
ASJC Scopus subject areas
- Hematology
Cite this
Home care of acute leukaemia patients : From active therapy to end-of-life and palliative care. The 3-year experience of a single centre. / Capodanno, Isabella; Tamagnini, Enrica; Alfieri, Pierluigi; Codeluppi, Katia; Luminari, Stefano; Merli, Francesco.
In: European Journal of Haematology, 01.01.2019.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Home care of acute leukaemia patients
T2 - From active therapy to end-of-life and palliative care. The 3-year experience of a single centre
AU - Capodanno, Isabella
AU - Tamagnini, Enrica
AU - Alfieri, Pierluigi
AU - Codeluppi, Katia
AU - Luminari, Stefano
AU - Merli, Francesco
PY - 2019/1/1
Y1 - 2019/1/1
N2 - Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82%) required palliative treatment, and eight (18%) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4% of patients and in hospital for 40.5%. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6% and 65%, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.
AB - Purpose: The aim of the study was to evaluate the feasibility and the potential effects of the Haematological Home Care (HHC) programme for acute leukaemia (AL) patients, either in active chemotherapy or in the terminal phase of disease. Methods: We retrospectively assessed a group of AL patients assisted at home in terms of number of hospitalisations, accesses to emergency department and place of death. We also used historical data to evaluate potential effects of HHC. Results: The study group consisted of 44 patients, 36 of whom (82%) required palliative treatment, and eight (18%) had ongoing active chemotherapy. The mean number of hospitalisations was 0.64 (range 0-7) per patient, and the number of emergency department (ED) visits was 0.82 (range 0-4) per patient. Place of death was at home for 51.4% of patients and in hospital for 40.5%. Considering a historical group of 17 patients assisted at home the rate of hospitalisations and ED visits were 2.53 (range 0-9) and one (range 0-3), respectively. Place of death was home and hospital in 6% and 65%, respectively. Conclusions: Haematological Home Care for AL patients is feasible and has potential positive effects in terms rate of hospitalisations and place of death.
KW - acute leukaemia
KW - home care
KW - palliative care
KW - supportive care
UR - http://www.scopus.com/inward/record.url?scp=85062962347&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062962347&partnerID=8YFLogxK
U2 - 10.1111/ejh.13224
DO - 10.1111/ejh.13224
M3 - Article
AN - SCOPUS:85062962347
JO - European Journal of Haematology
JF - European Journal of Haematology
SN - 0902-4441
ER -